Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Askanase, Anca D; Zhao, Enxu; Zhu, Julie; Bilyk, Roman; Furie, Richard A

Askanase, Anca D; Zhao, Enxu; Zhu, Julie; Bilyk, Roman; Furie, Richard A.

Afiliación

Askanase AD; Columbia University Medical Center, New York, NY, USA. ada20@cumc.columbia.edu.
Zhao E; Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Zhu J; Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Bilyk R; Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Furie RA; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

Rheumatol Ther ; 7(4): 893-908, 2020 Dec.

Article en En | MEDLINE | ID: mdl-32996096

Palabras clave

Acthar Gel; Autoimmune disease; Clinical trial; Corticosteroid; Glucocorticoid; Inflammation; Repository corticotropin injection; Systemic lupus erythematosus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Rheumatol Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google